REGISTERED
on 03 Dec 2024
Last Applicant/ Owned by
149 Fifth Avenue, Suite 500
New York
NY
10010
Serial Number
97160435 filed on 07th Dec 2021
Registration Number
7589136 registered on 03rd Dec 2024
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
PROTAGENIC THERAPEUTICS
Pharmaceutical products for the treatment of stress, PTSD, depression anxiety, addiction, addiction withdrawal symptoms, brain functions, neuropsychiatric disorders, and neurodegenerative diseases
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical products for the treatment of stress, PTSD, depression anxiety, addiction, addiction withdrawal symptoms, brain functions, neuropsychiatric disorders, and neurodegenerative diseases
First Use Date in General
29th Aug 2023
First Use Date in Commerce
29th Aug 2023
Mark Details
Serial Number
No 97160435
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
01.01.02 -
A single star with four points
26.01.13 -
Two circles
26.01.21 -
Circles that are totally or partially shaded
Legal History
| Status Date | Action Taken |
|---|---|
| 03rd Dec 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 03rd Dec 2024 | REGISTERED-PRINCIPAL REGISTER |
| 16th Feb 2024 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| 13th Feb 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 13th Feb 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 12th Feb 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 10th Feb 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| 10th Feb 2024 | SOU EXTENSION 1 GRANTED |
| 10th Feb 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 22nd Jan 2024 | NOTICE OF REVIVAL - E-MAILED |